{
    "organizations": [],
    "uuid": "6743df271d4bebc6d394c419e766df8814725cc7",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-curis-announces-initiation-of-phas/brief-curis-announces-initiation-of-phase-1-trial-of-ca-4948-idUSASB0C17O",
    "ord_in_thread": 0,
    "title": "BRIEF-Curis Announces Initiation Of Phase 1 Trial Of CA-4948",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "Jan 17 (Reuters) - Curis Inc:\n* CURIS ANNOUNCES INITIATION OF PHASE 1 TRIAL OF CA-4948, A SMALL MOLECULE INHIBITOR OF IRAK4 KINASE IN PATIENTS WITH LYMPHOMA Source text for Eikon: Further company coverage:\n ",
    "published": "2018-01-17T20:50:00.000+02:00",
    "crawled": "2018-01-18T16:24:04.098+02:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "jan",
        "reuters",
        "curis",
        "inc",
        "curis",
        "announces",
        "initiation",
        "phase",
        "trial",
        "small",
        "molecule",
        "inhibitor",
        "irak4",
        "kinase",
        "patient",
        "lymphoma",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}